Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Releasing the Brakes on CD8+ T Cells in the Melanoma Sentinel Lymph Node by Pre-operative Local Administration of Low-dose Anti-CTLA-4 (Tremelimumab)

NCT04274816 is registered in ClinicalTrials.gov with A.J.M. van den Eertwegh as lead sponsor.

NCT NCT04274816
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04274816 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Releasing the Brakes on CD8+ T Cells in the Melanoma Sentinel Lymph Node by Pre-operative Local Administration of Low-dose Anti-CTLA-4 (Tremelimumab)
Lead sponsor
A.J.M. van den Eertwegh
Phase
Phase 1
Overall status
Completed
Start date
July 10, 2012
Completion date
February 27, 2014
Enrollment
13 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous melanoma